Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: Business Wire
EQ504 protects against gut damage in a mouse model of ulcerative colitisEQ504 increases Treg stability and function while suppressing pathogenic Th17 responsesEQ504 promotes healing of intestinal epithelial cells by promoting anti-inflammatory cytokines LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that three posters were presented at IMMUNOLOGY2025, the annual meeting of The American Association of Immunologists taking place at the Hawai?i Convention Center in Honolulu, Hawaii, May 3 – 7.“Decades of independent research have validated AhR as an important physiological regulator of immune homeostasis in barrier tissues such as the gut,” said Dr. Stephen Connelly, chief scientific officer at Equillium. “These data demonstrate the potent activity of EQ504 in suppressing inflammat
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Equillium (EQ) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $7.00 price target on the stock.MarketBeat
- Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island EventGlobeNewswire
- Equillium (EQ) had its "buy" rating reaffirmed by Roth Mkm. They now have a $12.00 price target on the stock.MarketBeat
- Equillium (EQ) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $6.00 price target on the stock.MarketBeat
EQ
Sec Filings
- 5/7/26 - Form SCHEDULE
- 4/17/26 - Form EFFECT
- 4/15/26 - Form ARS
- EQ's page on the SEC website